Effects of Intrauterine Administration of Autologous PBMC on the Endometrial Cells Populations

Recruiting N/A Interventional Study
Female Infertility
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
20 – 50
Sex
Female
Study type
Interventional
Purpose
Treatment
Participants needed
300 (estimated)
Sponsor
Nadezhda Women's Health Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The behaviour of the endometrium during its receptive phase is highly dependent on the endometrial cell type composition. Each cell type has its role in the endometrial preparation for the invading embryo. Alteration in the immune cells dialogue could be the main reason for unsuccessful implantation in certain patients. Immune cell homeostasis is often improved by intrauterine administration of au…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Participating in Assisted Reproduction Treatment * Presenting altered endometrial immune profile * Having primary infertility * Having regular menstrual cycles * Embryo transfer of euploid embryos Exclusion Criteria: * Uterine pathologies * Endometrial Bacterial infections *…
Contacts

Georgi Stamenov, MD

+359888269839

g.stamenov@abv.bg

CONTACT

Rumiana Ganeva, MSc

+359898484825

rum.ganeva@gmail.com

CONTACT